SUTRO BIOPHARMA, INC. vs 4D Molecular Therapeutics, Inc., risk disclosures compared

4topics both disclose

5only SUTRO BIOPHARMA, INC.

0only 4D Molecular Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	SUTRO BIOPHARMA, INC.	4D Molecular Therapeutics, Inc.
Internal Control	5	6
Ransomware	7	3
Restatement	2	5
Third Party Risk Management	3	3

Only SUTRO BIOPHARMA, INC.

Topic	Filings
Business Continuity	27
Material Weakness	5
Regulatory Investigation	4
Records Retention	2
Regulatory Reporting	1

Only 4D Molecular Therapeutics, Inc.

Nothing.

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

SUTRO BIOPHARMA, INC. · 4D Molecular Therapeutics, Inc. · All companies